Hansjürgen Agostini

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals

Hansjürgen Agostini, Caroline F. Ryschkewitsch, G. L. Stoner · Journal of Clinical Microbiology · 1996 · 204 citations · Full text

Viral Diagnostics, Immunology, Pathology +16

Asian genotypes of JC virus in Native Americans and in a Pacific Island population: Markers of viral evolution and human migration

Hansjürgen Agostini, Richard Yanagihara, Victor Davis et al. · Proceedings of the National Academy of Sciences · 1997 · 194 citations · Full text

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV

Thomas Wecker, Christoph Ehlken, Anima Bühler et al. · British Journal of Ophthalmology · 2016 · 165 citations · Full text

Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients

Christoph Ehlken, Mandy Helms, Daniel Böhringer et al. · Clinical ophthalmology · 2017 · 156 citations · Full text